Copyright Reports & Markets. All rights reserved.

Global Human Vaccine Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Human Vaccine Market Overview

      • 1.1 Product Overview and Scope of Human Vaccine
      • 1.2 Human Vaccine Segment by Type
        • 1.2.1 Global Human Vaccine Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Varicella
        • 1.2.3 Influenza
        • 1.2.4 Polio
        • 1.2.5 Hepatitis A
        • 1.2.6 Rabies
        • 1.2.7 BCG
        • 1.2.8 Hepatitis B
        • 1.2.9 Pertussis, Diphtheria, Tetanus
        • 1.2.10 Pneumococcal
        • 1.2.11 Rota vaccine
      • 1.3 Human Vaccine Segment by Application
        • 1.3.1 Human Vaccine Consumption Comparison by Application (2014-2025)
        • 1.3.2 Adults
        • 1.3.3 Children
      • 1.4 Global Human Vaccine Market by Region
        • 1.4.1 Global Human Vaccine Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Human Vaccine Market Size
        • 1.5.1 Global Human Vaccine Revenue (2014-2025)
        • 1.5.2 Global Human Vaccine Production (2014-2025)

      2 Global Human Vaccine Market Competition by Manufacturers

      • 2.1 Global Human Vaccine Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Human Vaccine Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Human Vaccine Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Human Vaccine Production Sites, Area Served, Product Types
      • 2.5 Human Vaccine Market Competitive Situation and Trends
        • 2.5.1 Human Vaccine Market Concentration Rate
        • 2.5.2 Human Vaccine Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Human Vaccine Production Market Share by Regions

      • 3.1 Global Human Vaccine Production Market Share by Regions
      • 3.2 Global Human Vaccine Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Human Vaccine Production
        • 3.4.1 North America Human Vaccine Production Growth Rate (2014-2019)
        • 3.4.2 North America Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Human Vaccine Production
        • 3.5.1 Europe Human Vaccine Production Growth Rate (2014-2019)
        • 3.5.2 Europe Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Human Vaccine Production (2014-2019)
        • 3.6.1 China Human Vaccine Production Growth Rate (2014-2019)
        • 3.6.2 China Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Human Vaccine Production (2014-2019)
        • 3.7.1 Japan Human Vaccine Production Growth Rate (2014-2019)
        • 3.7.2 Japan Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Human Vaccine Consumption by Regions

      • 4.1 Global Human Vaccine Consumption by Regions
      • 4.2 North America Human Vaccine Consumption (2014-2019)
      • 4.3 Europe Human Vaccine Consumption (2014-2019)
      • 4.4 China Human Vaccine Consumption (2014-2019)
      • 4.5 Japan Human Vaccine Consumption (2014-2019)

      5 Global Human Vaccine Production, Revenue, Price Trend by Type

      • 5.1 Global Human Vaccine Production Market Share by Type (2014-2019)
      • 5.2 Global Human Vaccine Revenue Market Share by Type (2014-2019)
      • 5.3 Global Human Vaccine Price by Type (2014-2019)
      • 5.4 Global Human Vaccine Production Growth by Type (2014-2019)

      6 Global Human Vaccine Market Analysis by Applications

      • 6.1 Global Human Vaccine Consumption Market Share by Application (2014-2019)
      • 6.2 Global Human Vaccine Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Human Vaccine Business

      • 7.1 CNBG
        • 7.1.1 CNBG Human Vaccine Production Sites and Area Served
        • 7.1.2 Human Vaccine Product Introduction, Application and Specification
        • 7.1.3 CNBG Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Changsheng Life
        • 7.2.1 Changsheng Life Human Vaccine Production Sites and Area Served
        • 7.2.2 Human Vaccine Product Introduction, Application and Specification
        • 7.2.3 Changsheng Life Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Zhifei
        • 7.3.1 Zhifei Human Vaccine Production Sites and Area Served
        • 7.3.2 Human Vaccine Product Introduction, Application and Specification
        • 7.3.3 Zhifei Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 ChengDa Bio
        • 7.4.1 ChengDa Bio Human Vaccine Production Sites and Area Served
        • 7.4.2 Human Vaccine Product Introduction, Application and Specification
        • 7.4.3 ChengDa Bio Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Kangtai
        • 7.5.1 Kangtai Human Vaccine Production Sites and Area Served
        • 7.5.2 Human Vaccine Product Introduction, Application and Specification
        • 7.5.3 Kangtai Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 SINOVAC BIOTECH
        • 7.6.1 SINOVAC BIOTECH Human Vaccine Production Sites and Area Served
        • 7.6.2 Human Vaccine Product Introduction, Application and Specification
        • 7.6.3 SINOVAC BIOTECH Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Hissen
        • 7.7.1 Hissen Human Vaccine Production Sites and Area Served
        • 7.7.2 Human Vaccine Product Introduction, Application and Specification
        • 7.7.3 Hissen Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Walvax Biotechnology
        • 7.8.1 Walvax Biotechnology Human Vaccine Production Sites and Area Served
        • 7.8.2 Human Vaccine Product Introduction, Application and Specification
        • 7.8.3 Walvax Biotechnology Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 GSK
        • 7.9.1 GSK Human Vaccine Production Sites and Area Served
        • 7.9.2 Human Vaccine Product Introduction, Application and Specification
        • 7.9.3 GSK Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 SANOFI
        • 7.10.1 SANOFI Human Vaccine Production Sites and Area Served
        • 7.10.2 Human Vaccine Product Introduction, Application and Specification
        • 7.10.3 SANOFI Human Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Rong An
      • 7.12 NuoCheng Bio
      • 7.13 Hualan Bio
      • 7.14 Tiantan biological
      • 7.15 Changchun Baike
      • 7.16 Adimmune
      • 7.17 Zhongyianke Biotech

      8 Human Vaccine Manufacturing Cost Analysis

      • 8.1 Human Vaccine Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Human Vaccine
      • 8.4 Human Vaccine Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Human Vaccine Distributors List
      • 9.3 Human Vaccine Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Human Vaccine Market Forecast

      • 11.1 Global Human Vaccine Production, Revenue Forecast
        • 11.1.1 Global Human Vaccine Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Human Vaccine Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Human Vaccine Price and Trend Forecast (2019-2025)
      • 11.2 Global Human Vaccine Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Human Vaccine Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Human Vaccine Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Human Vaccine Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Human Vaccine Production, Revenue Forecast (2019-2025)
      • 11.3 Global Human Vaccine Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Human Vaccine Consumption Forecast (2019-2025)
        • 11.3.2 Europe Human Vaccine Consumption Forecast (2019-2025)
        • 11.3.3 China Human Vaccine Consumption Forecast (2019-2025)
        • 11.3.4 Japan Human Vaccine Consumption Forecast (2019-2025)
      • 11.4 Global Human Vaccine Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Human Vaccine Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
        The average price of China Human Vaccine is in the increasing trend, from 4.14 USD/Dose in 2013 to 4.49 USD/Dose in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
        The classification of China Human Vaccine includes Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Rota vaccine and other kinds of vaccines, and the proportion of Rabies in 2017 is about 20.4%, and the proportion is in fluctuation trend from 2013 to 2017.

        The global Human Vaccine market is valued at 14100 million US$ in 2018 is expected to reach 30600 million US$ by the end of 2025, growing at a CAGR of 10.2% during 2019-2025.
        This report focuses on Human Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Human Vaccine market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        CNBG
        Changsheng Life
        Zhifei
        ChengDa Bio
        Kangtai
        SINOVAC BIOTECH
        Hissen
        Walvax Biotechnology
        GSK
        SANOFI
        Rong An
        NuoCheng Bio
        Hualan Bio
        Tiantan biological
        Changchun Baike
        Adimmune
        Zhongyianke Biotech

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Varicella
        Influenza
        Polio
        Hepatitis A
        Rabies
        BCG
        Hepatitis B
        Pertussis, Diphtheria, Tetanus
        Pneumococcal
        Rota vaccine

        Segment by Application
        Adults
        Children

        Buy now